Provision of services for trauma- and stressor-related (TSR) disorders during a pandemic: Investigating the Utility of Reconsolidation Therapy Delivered Online
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 174923
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$190,370.25Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Alain F BrunetResearch Location
CanadaLead Research Institution
CIUSSS de l'Ouest de l'Ile de Montréal Douglas HospitalResearch Priority Alignment
N/A
Research Category
Health Systems Research
Research Subcategory
Health service delivery
Special Interest Tags
Digital Health
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The COVID-19 pandemic has induced a variety of trauma- and stressor-related (TSR) disorders in the population, according to a large international online survey conducted by our research team in May 2020. There currently exists a knowledge gap in our capacity to diagnose and treat these common mental disorders in confinement settings (e.g., via tele-heath). We aim to build capacity by (1) training providers to deliver an evidence-based treatment (Reconsolidation Therapy) using an on-line delivery format and (2) pilot-testing Reconsolidation Therapy, an evidence-based treatment developed by our team to treat TSR disorders, and (3) disseminate widely this knowledge via project partner, the Canadian Psychological Association. We will be using both quantitative (statistics) and qualitative (narratives generated by group interviews) methods to adapt current diagnostic assessments to an online format, as well as evaluate the treatment ease of delivery and (preliminary) efficacy. Considering the uncertainty of the COVID-19 pandemic and its duration, our project will contribute to the development of secure, accessible, and evidence-based online treatments for STRD that meets the needs of patients and treatment providers in Canada and beyond.